VF
BTAL icon

VitalStone Financial’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

VitalStone Financial’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.67M Buy
85,335
+27,885
+49% +$555K 1.14% 21
2024
Q2 		$1.13M Buy
57,450
+29,969
+109% +$569K 0.82% 23
2024
Q1 		$495K Buy
27,481
+24,686
+883% +$448K 0.38% 51
2023
Q4 		$47K Buy
2,795
+2,742
+5,174% +$54.5K 0.04% 158
2023
Q3 		$1K Buy
+53
New +$1K ﹤0.01% 401

Other funds holding BTAL

TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $18.3B AUM 27.14% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
CWG
Cornerstone Wealth Group Huntersville, North Carolina $1.69B AUM 28.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return

VitalStone Financial's BTAL Position: Q3 2024 in Review

VitalStone Financial increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 49% in Q3 2024, buying an estimated $555K and bringing the position to 85,335 shares worth $1.67M. The position accounts for 1.14% of the portfolio, ranked #21.

VitalStone Financial first reported a position in BTAL in Q3 2023 and has held it in 5 quarters since. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2024.

  • VitalStone Financial held 85,335 shares of AGF US Market Neutral Anti-Beta Fund worth $1.67M as of Q3 2024.
  • VitalStone Financial bought 27,885 AGF US Market Neutral Anti-Beta Fund shares in Q3 2024, an estimated $555K.
  • AGF US Market Neutral Anti-Beta Fund made up 1.14% of VitalStone Financial's portfolio in Q3 2024, its #21 holding.
  • VitalStone Financial first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2023 and has held it in 5 quarters since.
  • 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2024.

Based on VitalStone Financial's 13F filing for Q3 2024, filed 11 Oct 2024.